Thirty three marine species are poised to invade Australian waters, and could seriously alter the balance of marine life or even pose a risk to human health if they reach our coasts.

Prima BioMed subsidiary Cancer Vac has announced positive results from the Phase Ib clinical trial of its cancer vaccine immunotherapy. [ + ]

Brisbane firm Alchemia has capped a lengthy hunt for additional investment by securing $2.75 million in fresh funding, according to CEO Tracie Ramsdale. [ + ]

Meditech Research is to start clinical trials on its HyCAMP anti-cancer compound, targeting colorectal tumours in patients at the Centre for the Development of Cancer Therapeutics in Melbourne. [ + ]

Peptech's application for a patent on antibodies or antibody fragments that bind to a specific tumour necrosis factor (TNF) has been given the green light by US patent authorities. [ + ]

Australian windpower technology is reaching out to a global market, as science, technology and industry come together in a new wind energy consulting company based in Canberra.

Bionomics has entered into a standby equity facility with an affiliate of the Bank of New York, allowing the company to sell up to six million shares through the affiliate group over the next three years. [ + ]

A special BioBusiness Forum will be held in Sydney on July 22 to go over issues raised by the recent Biotechnology Alliance signed by the premiers of NSW, Victoria and Queensland. [ + ]

Research into new technologies which will underpin business decisions to invest billions of dollars in environmentally-friendly forests is the focus of a new book published by CSIRO and the Australian Academy of Technological Sciences and Engineering.

At a time when water is becoming a more highly valued commodity, research by the University of Adelaide shows Australian farmers can potentially save water on crops without losing profits - and at the same time, increase their yields.

Australian and US researchers have combined efforts to produce artistic rat cells, which can paint pictures across the world from their Petri dish. And hopefully give some insight into the learning process at the same time. [ + ]

The Royal College of Pathologists of Australasia (RCPA) and associated genetics organisations, including the Human Genetics Society of Australia, have retracted and clarified recent statements made in a letter to state and Federal government officials, which suggested that Melbourne biotech company Genetic Technologies would seek to enforce the breast cancer gene patents licensed to it by Myriad Genetics. [ + ]

Thrombosis diagnostic specialist Agenix has successfully detected a deep vein thrombosis (DVT) clot in the leg of a patient during Phase Ib clinical trials. [ + ]

Australian geneticist Malcolm Simons has hit back at critics of the controversial international patents he secured in the 1990s for the use of non-coding DNA to predict individuals' genetic risk of developing diseases like cancer and cardiovascular disease. [ + ]

The kangaroo genome project has moved slightly closer to reality with the announcement that the Australian Research Council will fund a new Centre for the Kangaroo Genome, worth AUD$2.6 million over the next five years. [ + ]